Literature DB >> 24290142

Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.

Yong-Il Kim1, Seok-Ki Kim2, Jin Chul Paeng3, Ho-Young Lee4.   

Abstract

OBJECTIVE: Pancreatic solid pseudopapillary tumor (SPT) is a rare benign tumor. Little data are available on positron emission tomographic/computed tomographic (PET/CT) characteristics of this tumor. Therefore, we analyzed the metabolic characteristics of SPT using F-18-FDG PET/CT and compared the results with those of pancreatic ductal adenocarcinoma.
METHODS: We retrospectively reviewed the records of 11 SPT patients and 46 patients with ductal adenocarcinoma. Ten SPT patients had primary tumors and 1 patient had metastatic SPT. Maximum standardized uptake value (max SUV), mean SUV, metabolic tumor volume (MTV), total lesion glycolysis (TLG), and tumor-to-background ratio (TBR) were evaluated. Mann-Whitney U test between pancreatic SPT and ductal adenocarcinoma was performed. In addition, age, gender and tumor size-adjusted analysis of covariance (ANCOVA) was done between pancreatic SPT and ductal adenocarcinoma.
RESULTS: Compared with pancreatic ductal adenocarcinomas, SPTs had significantly higher tumor size-adjusted MTV and TLG. MTV and TLG values were significantly correlated with T-stage of the SPTs. In 1 SPT patient, metastases in the liver and mesentery were revealed by intense uptake of FDG on F-18-FDG PET/CT, and after PET/CT had suggested the presence of pancreatic SPT.
CONCLUSION: We recommend that SPT be considered when a solid pancreatic mass with increased FDG metabolism is encountered on PET/CT. F-18-FDG PET/CT may be useful in detecting subtle metastases of SPT.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Metabolic tumor volume; Pancreatic cancer; Positron emission tomography; Solid pseudopapillary tumor; Standardized uptake value; Total lesion glycolysis

Mesh:

Substances:

Year:  2013        PMID: 24290142     DOI: 10.1016/j.ejrad.2013.09.031

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 2.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

3.  Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.

Authors:  Min Young Yoo; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; E Edmund Kim; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-08-29

4.  Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.

Authors:  Hyung-Jun Im; Suthet Oo; Woohyun Jung; Jin-Young Jang; Sun-Whe Kim; Gi Jeong Cheon; Keon Wook Kang; June-Key Chung; E Edmund Kim; Dong Soo Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Aggressiveness of solid pseudopapillary neoplasm of the pancreas: A literature review and meta-analysis.

Authors:  Emmanuel Ii Uy Hao; Ho Kyung Hwang; Dong-Sub Yoon; Woo Jung Lee; Chang Moo Kang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.

Authors:  Altay Myssayev; Ayan Myssayev; Reiko Ideguchi; Susumu Eguchi; Tomohiko Adachi; Yorihisa Sumida; Shuichi Tobinaga; Masataka Uetani; Takashi Kudo
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

7.  Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms.

Authors:  Keisuke Kurihara; Keiji Hanada; Masahiro Serikawa; Yasutaka Ishii; Tomofumi Tsuboi; Ryota Kawamura; Tsuyoshi Sekitou; Shinya Nakamura; Takeshi Mori; Tetsuro Hirano; Juri Ikemoto; Kazuaki Chayama
Journal:  Pancreas       Date:  2019 Nov/Dec       Impact factor: 3.327

8.  Contrast-enhanced fluorodeoxyglucose positron emission tomography/computed tomography in solid pseudopapillary neoplasm of the pancreas.

Authors:  Sampath Santhosh; Ramesh Kumar Lakshmanan; Bhavay Sonik; Rajagopalan Padmavathy; Rajamani Emmanuel Gunaseelan
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun

9.  Metabolic characteristics of solid pseudopapillary neoplasms of the pancreas: their relationships with high intensity 18F-FDG PET images.

Authors:  Minhee Park; Ho Kyoung Hwang; Mijin Yun; Woo Jung Lee; Hoguen Kim; Chang Moo Kang
Journal:  Oncotarget       Date:  2018-01-03

Review 10.  Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas.

Authors:  Li You; Feng Yang; De-Liang Fu
Journal:  World J Gastrointest Oncol       Date:  2018-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.